Master Services AgreementMaster Services Agreement • August 26th, 2015 • Prana Biotechnology LTD • Pharmaceutical preparations • Delaware
This Master Services Agreement (this “Agreement”) is made and entered into as of the date of the last party to sign (the “Effective Date”) between Certara, L.P., a Delaware limited partnership, via its branch, Certara, L.P. Sucursal em Portugal (hereinafter “Certara Portugal”), and Prana Biotechnology Ltd ACN 080 699 065, an Australian public company with its principal office at Level 2, 369 Royal Parade, Parkville, Victoria 3052 Australia (hereinafter “Customer”).
D3 MEDICINE LLC MASTER SERVICES AGREEMENTMaster Services Agreement • August 26th, 2015 • Prana Biotechnology LTD • Pharmaceutical preparations • Victoria
This Master Services Agreement (this “Agreement”), effective 17 March, 2015 (the “Effective Date”), is entered into by and between d3 Medicine LLC, a limited liability company having offices at 4 Century Drive, 2nd Floor, Parsippany, NJ 07054, United States of America (“d3”) and Prana Biotechnology Ltd ACN 080 699 065, a limited liability company having offices at Level 2, 369 Royal Parade, Parkville Victoria 3052 (“Client”) (each herein referred to individually as a “Party,” or collectively as the “Parties”). In consideration of the covenants and conditions contained herein, the Parties hereby agree to the following:
THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH (ABN 92 124 762 027) AND PRANA BIOTECHNOLOGY LTD (ABN 37 080 699 065) SIXTH RESEARCH FUNDING AND INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENTAssignment Agreement • August 26th, 2015 • Prana Biotechnology LTD • Pharmaceutical preparations • Victoria
This Agreement restates and amends the Research Funding and Intellectual Property Assignment Agreements between the University of Melbourne and Prana which were novated to Florey under the Novation Deed, and provides for the further conduct of Research by Florey and Prana.
